NL-OMON34531
Completed
Not Applicable
Prospective study on the effects of withdrawal of anti-TNF therapy in patients with rheumatoid arthritis who are in remission- stop-study - AMC STOP
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Rheumatoid arthritis
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 40
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Men/women suffering from rheumatoid arthritis, based on the 2010 American College of Rheumatology/ European league Against Rheumatism (ACR/EULAR) classification criteria for RA will be included in this study.;Patients in ARA functional classes I, II, and III may be included.;In addition, patients must fulfill the following criteria at baseline:
- •1\) DAS 28 \* 2\.6 for the duration of a minimum of 24 weeks
- •2\) Be \> 18 years of age and \* 85 years.
- •3\) Stable use of concomitant DMARDs and TNF antagonists for the duration of 24 weeks before baseline
Exclusion Criteria
- •1\) The use of oral/ intra\-articular corticosteroids within 6 months prior to baseline
- •2\) Pregnancy
- •3\) Breastfeeding
- •4\) Subjects who are impaired, incapacitated, or incapable of completing study
- •related assessments.
- •5\) Subjects who meet diagnostic criteria for any other rheumatic disease (e.g., lupus
- •erythematous).
- •6\) Subjects with active vasculitis of a major organ system with the exception of
- •rheumatoid nodules.
- •7\) Subjects with current symptoms of severe, progressive, or uncontrolled renal,
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
The effect of withdrawal of PPI use for myocardial perfusion imaging.EUCTR2016-001383-10-NLRijnstate ziekenhuis
Active, not recruiting
Not Applicable
Instrumental and clinical effects of withdrawal of beta blockers therapy in patients with heart failure and right ventricular dysfunction'' - Destroheart failureMedDRA version: 14.1Level: LLTClassification code 10011949Term: Decompensation cardiacSystem Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2011-000890-29-ITFONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR
Completed
Not Applicable
Short TEG: cessation of clopidogrel following insertion of drug-eluting coronary stentsTopic: CardiovascularSubtopic: Cardiovascular (all Subtopics)Disease: CardiovascularCirculatory SystemPercutaneous coronary interventionISRCTN51917813Southampton University Hospitals NHS Trust (UK)60
Recruiting
Not Applicable
Prospective observational study of the effects of D-alanine intake on amino acid metabolismJPRN-UMIN000051466Kanazawa University24
Recruiting
Not Applicable
The effects of low-intensity DTT on mental and physical healthiness of ASD childreJPRN-jRCT1030210396Fujinaka Hidehiko10